Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.

J Pharmacol Toxicol Methods

Biological Reagents and Assay Development, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.

Published: October 2013

Introduction: Drug-induced prolongation of the QT interval via block of the hERG potassium channel is a major cause of attrition in drug development. The advent of automated electrophysiology systems has enabled the detection of hERG block earlier in drug discovery. In this study, we have evaluated the suitability of a second generation automated patch clamp instrument, the IonWorks Barracuda, for the characterization of hERG biophysics and pharmacology.

Methods: All experiments were conducted with cells stably expressing hERG. Recordings were made in perforated patch mode either on a conventional patch clamp setup or on the IonWorks Barracuda. On the latter, all recordings were population recordings in 384-well patch plates.

Results: HERG channels activated with a V(1/2)=-3.2±1.6mV (n=178) on the IonWorks Barracuda versus -11.2±6.1mV (n=9) by manual patch clamp. On the IonWorks Barracuda, seal resistances and currents were stable (<30% change) with up to six cumulative drug additions and 1-min incubations per addition. Over 27 experiments, an average of 338 concentration-response curves were obtained per experiment (96% of the 352 test wells on each plate). HERG pharmacology was examined with a set of 353 compounds that included well-characterized hERG blockers. Astemizole, terfenadine and quinidine inhibited hERG currents with IC(50) values of 159nM, 224nM and 2μM, respectively (n=51, 10 and 18). This set of compounds was also tested on the PatchXpress automated electrophysiology system. We determined through statistical methods that the two automated systems provided equivalent results.

Discussion: Evaluating drug effects on hERG channels is best performed by electrophysiological methods. HERG activation and pharmacology on the IonWorks Barracuda automated electrophysiology platform were in good agreement with published electrophysiology results. Therefore, the IonWorks Barracuda provides an efficient way to study hERG biophysics and pharmacology.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vascn.2012.10.002DOI Listing

Publication Analysis

Top Keywords

ionworks barracuda
16
patch clamp
12
potassium channel
8
herg
6
patch
5
development high-throughput
4
high-throughput electrophysiological
4
electrophysiological assay
4
assay human
4
human ether-à-go-go
4

Similar Publications

The voltage-gated sodium channel Nav1.7 is a genetically validated target for pain; pharmacological blockers are promising as a new class of nonaddictive therapeutics. The search for Nav1.

View Article and Find Full Text PDF

α7-Nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease.

AIDS

May 2017

aCollaborations Pharmaceuticals, Inc., Fuquay-Varina, North Carolina bLos Angeles BioMedical Research Institute cHarbor-UCLA Medical Center, Torrance dDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles ePsychiatry Department, Los Angeles BioMedical Research Institute, Torrance fDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles gPsychiatry Department, Harbor-UCLA Medical Center, Torrance, California, USA.

Objective: The study set out to determine if the HIV protease inhibitor, indinavir, alters responsiveness of α7-nicotinic acetylcholine receptors to acetylcholine.

Design: Treatment with HAART has dramatically reduced development of HIV-associated dementia and more severe forms of cognitive impairment. However, many individuals continue to experience cognitive decline of uncertain cause.

View Article and Find Full Text PDF

Nicotine, the addictive component of tobacco products, is an agonist at nicotinic acetylcholine receptors (nAChRs) in the brain. The subtypes of nAChR are defined by their α- and β-subunit composition. The α6β2β3 nAChR subtype is expressed in terminals of dopaminergic neurons that project to the nucleus accumbens and striatum and modulate dopamine release in brain regions involved in nicotine addiction.

View Article and Find Full Text PDF

Voltage-gated sodium channels represent important drug targets. The implementation of higher throughput electrophysiology assays is necessary to characterize the interaction of test compounds with several conformational states of the channel, but has presented significant challenges. We describe a novel high throughput approach to assess the effects of test agents on voltage-gated sodium currents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!